Sernova Biotherapeutics (TSX:SVA) Total Assets : C$3.08 Mil (As of Jan. 2025)

View and export this data going back to 1998. Start your Free Trial

What is Sernova Biotherapeutics Total Assets?

Sernova Biotherapeutics's Total Assets for the quarter that ended in Jan. 2025 was C$3.08 Mil.

During the past 12 months, Sernova Biotherapeutics's average Total Assets Growth Rate was -38.10% per year. During the past 3 years, the average Total Assets Growth Rate was -8.00% per year. During the past 5 years, the average Total Assets Growth Rate was 1.00% per year. During the past 10 years, the average Total Assets Growth Rate was 21.80% per year.

During the past 13 years, Sernova Biotherapeutics's highest 3-Year average Total Assets Growth Rate was 351.50%. The lowest was -47.20%. And the median was 6.70%.

Total Assets is connected with ROA %. Sernova Biotherapeutics's annualized ROA % for the quarter that ended in Jan. 2025 was -429.61%. Total Assets is also linked to Revenue through Asset Turnover. Sernova Biotherapeutics's Asset Turnover for the quarter that ended in Jan. 2025 was 0.00.

Sernova Biotherapeutics Total Assets Historical Data

The historical data trend for Sernova Biotherapeutics's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sernova Biotherapeutics Total Assets Chart

Sernova Biotherapeutics Annual Data

Trend

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Oct24

Total Assets

Get a 7-Day Free Trial

5.73

29.82

52.49

22.11

7.53

Sernova Biotherapeutics Quarterly Data
	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25
Total Assets	Get a 7-Day Free Trial															18.57	11.77	7.46	7.53	3.08

Sernova Biotherapeutics Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Sernova Biotherapeutics's Total Assets for the fiscal year that ended in Oct. 2024 is calculated as

Total Assets	=	Total Equity (A: Oct. 2024 )	+	Total Liabilities (A: Oct. 2024 )
	=	-12.957	+	20.484
	=	7.53

Sernova Biotherapeutics's Total Assets for the quarter that ended in Jan. 2025 is calculated as

Total Assets	=	Total Equity (Q: Jan. 2025 )	+	Total Liabilities (Q: Jan. 2025 )
	=	-17.928	+	21.007
	=	3.08

Sernova Biotherapeutics (TSX:SVA) Total Assets Explanation

Total Assets is connected with ROA %.

Sernova Biotherapeutics's annualized ROA % for the quarter that ended in Jan. 2025 is

ROA %	=	Net Income (Q: Jan. 2025 )	/	( (Total Assets (Q: Oct. 2024 )	+	Total Assets (Q: Jan. 2025 ))	/ count )
	=	-22.78	/	( (7.527	+	3.078)	/ 2 )
	=	-22.78	/	5.3025
	=	-429.61 %

Note: The Net Income data used here is four times the quarterly (Jan. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Sernova Biotherapeutics's Asset Turnover for the quarter that ended in Jan. 2025 is

	Asset Turnover
=	Revenue (Q: Jan. 2025 )	/	( (Total Assets (Q: Oct. 2024 )	+	Total Assets (Q: Jan. 2025 ))	/ count )
=	0	/	( (7.527	+	3.078)	/ 2 )
=	0	/	5.3025
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Sernova Biotherapeutics Total Assets Related Terms

Thank you for viewing the detailed overview of Sernova Biotherapeutics's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Sernova Biotherapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sernova Biotherapeutics Inc (TSX:SVA) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

SEOVF:USA PSH0:Germany

Address

700 Collip Circle, Suite 114, London, ON, CAN, N6G 4X8

Website

https://www.sernova.com

Sernova Biotherapeutics Inc is a clinical-stage company developing regenerative medicines. The company develops Cell Pouch with human donor cells or stem cells to create a biohybrid organ. The Cell Pouch is a implantable medical device designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells, which then release proteins, hormones, or other factors into the bloodstream for the long-term treatment of multiple chronic diseases such as type 1 diabetes, hypothyroid disease, and rare diseases such as hemophilia A.

Executives